2024-10-29FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemiaDrug Scemblix (asciminib) · STAMP inhibitorConditionsMyeloidOther hematologic neoplasm
2021-10-29FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukemiaDrug Scemblix (asciminib) · STAMP inhibitorConditionsMyeloidOther hematologic neoplasm